Praxis Precision Medicines
MA - BostonBiotechnology
Focus: Praxis Precision Medicines is a Boston-based biotech focused on genetic neuroscience treatments, with a pipeline spanning major depressive disorder, epilepsy, essential tremor, and rare developmental encephalopathies. The company is actively hiring across 79 open roles, signaling growth-stage momentum.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Open Jobs
143+77 this month
Hot — 95 jobs added in 30d
Net +77 (95 new, 18 removed). Aggressive expansion phase.
Should You Work at Praxis Precision Medicines?
AI assessmentPraxis is a high-upside clinical-stage biotech with credible near-term catalysts (Phase 3 readouts, potential approvals) and commercial hiring momentum—suitable for risk-tolerant candidates seeking early-stage equity upside and therapeutic impact in neurology.
Why Work Here
- Pipeline depth: 16 active programs across Phase 1–3, with multiple Phase 3 assets (vormatrogine, ulixacaltamide, elsunersen, PRAX-562) approaching commercial readiness in high-need neurology indications.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developme
SCN2A-DEEClinical Trials (1)
NCT05407727A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy
N/AHelp build intelligence for Praxis Precision Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.